Physician profile
Sadaf Halimi
NPI 1780570341
$355.81
in general payments reported to CMS, 2019-2025
9 companies · $356 in 2025
The $356 reported for 2025 was more than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2025: $356.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $356.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $355.81 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Vertex Pharmaceuticals Incorporated | $87.80 | 2025 | |
| Forte Bio-Pharma LLC | $59.95 | 2025 | Prolate, Nalocet, Tanlor |
| Abbvie INC. | $53.21 | 2025 | |
| Averitas Pharma INC. | $48.99 | 2025 | Qutenza |
| Tersera Therapeutics LLC | $28.94 | 2025 | Prialt |
| Axsome Therapeutics, INC. | $24.94 | 2025 | Symbravo |
| Scilex Pharmaceuticals INC. | $20.88 | 2025 | |
| Valinor Pharma, LLC | $17.30 | 2025 | Movantik |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $13.80 | 2025 | Relistor |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sadaf Halimi listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.